Afnan I. Shahin
Sharjah, SH, United Arab Emirates
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Novel indole-based sulfonate and sulfamate derivatives as potent and selective urease inhibitors targeting Helicobacter pylori: a promising therapeutic strategy.
Journal: Gut pathogens
Published: November 18, 2025
An overview of RAF kinases and their inhibitors (2019-2023).
Journal: European journal of medicinal chemistry
Published: May 07, 2024
An overview of the latest outlook of sulfamate derivatives as anticancer candidates (2020-2024).
Journal: Archiv der Pharmazie
Published: April 30, 2024
Design, synthesis, biological evaluation, and in silico studies of novel pyridopyridine derivatives as anticancer candidates targeting FMS kinase.
Journal: European journal of medicinal chemistry
Published: April 29, 2024
Evaluation of 2,3-dihydroimidazo[2,1-b]oxazole and imidazo[2,1-b]oxazole derivatives as chemotherapeutic agents.
Journal: Future medicinal chemistry
Published: October 10, 2023
Design and synthesis of novel anti-urease imidazothiazole derivatives with promising antibacterial activity against Helicobacter pylori.
Journal: PloS one
Published: April 06, 2023
Complexity-to-Diversity and Pseudo-Natural Product Strategies as Powerful Platforms for Deciphering Next-Generation Therapeutics.
Journal: ChemMedChem
Published: February 27, 2023
Design and synthesis of new adamantyl derivatives as promising antiproliferative agents.
Journal: European journal of medicinal chemistry
Published: November 03, 2022
Design and synthesis of new quinoline derivatives as selective C-RAF kinase inhibitors with potent anticancer activity.
Journal: European journal of medicinal chemistry
Published: December 27, 2021
A Review of HER4 (ErbB4) Kinase, Its Impact on Cancer, and Its Inhibitors.
Journal: Molecules (Basel, Switzerland)
Published: November 17, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026